• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠心病患者与非冠心病患者抑郁情绪与纤溶酶原激活物抑制剂、组织纤溶酶原激活物及纤维蛋白原水平的关系。

Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.

作者信息

Lahlou-Laforet Khadija, Alhenc-Gelas Martine, Pornin Maurice, Bydlowski Sarah, Seigneur Etienne, Benetos Athanase, Kierzin Jean-Michel, Scarabin Pierre-Yves, Ducimetiere Pierre, Aiach Martine, Guize Louis, Consoli Silla M

机构信息

Department of C-L Psychiatry, Faculté de Médecine, Université Paris-Descartes, AP-HP, Hôpital Europeén Georges Pompidou, France.

出版信息

Am J Cardiol. 2006 May 1;97(9):1287-91. doi: 10.1016/j.amjcard.2005.11.062. Epub 2006 Mar 20.

DOI:10.1016/j.amjcard.2005.11.062
PMID:16635597
Abstract

The increased risk of coronary heart disease (CHD) associated with depression is well documented. We hypothesized that impaired fibrinolysis is involved in this link. To explore the association of depressive mood and/or vital exhaustion with various measurements of fibrinolysis activity, 231 men (40 to 65 years old; 123 without CHD and taking no medication and 108 with documented CHD), completed the Center of Epidemiologic Studies Depression Scale and the Maastricht Questionnaire for vital exhaustion. Using classic cut-off points (Center of Epidemiologic Studies Depression Scale score >or=17, Maastricht Questionnaire score >or=8), 6.5% and 9.8% of subjects without CHD and 38% and 48.1% of those with CHD were classified as depressed and exhausted, respectively. Patients with CHD were older, had a higher body mass index, and higher levels of total cholesterol, glucose, plasminogen activator inhibitor 1 (PAI-1), tissue plasminogen activator (t-PA) antigen, and fibrinogen; 47% were treated for hypertension. Depressed subjects had higher levels of PAI-1 activity (p = 0.006) and exhausted patients had higher levels of PAI-1 activity (p = 0.011) and fibrinogen (p = 0.009). After adjusting for clinical condition (with or without CHD), smoking, hypertension, triglyceride concentration, and body mass index, PAI-1 activity remained higher in depressed subjects (p = 0.03). This association persisted after further adjustment for vital exhaustion or for t-PA antigen and fibrinogen levels. t-PA antigen and fibrinogen levels were not associated with depressive mood in multivariate analyses. No fibrinolytic variable was associated with vital exhaustion in multivariate analyses. In conclusion, depressive mood, but not vital exhaustion, is associated with higher levels of PAI-1 activity, suggesting a possible impairment of fibrinolysis and indicating a potential additional mechanism by which depressive mood may act as a cardiovascular risk factor.

摘要

抑郁症与冠心病(CHD)风险增加之间的关联已有充分记录。我们推测纤维蛋白溶解功能受损与这一联系有关。为了探究抑郁情绪和/或过度疲劳与纤维蛋白溶解活性的各种测量指标之间的关联,231名男性(年龄在40至65岁之间;123名无冠心病且未服用药物,108名有确诊冠心病)完成了流行病学研究中心抑郁量表和马斯特里赫特过度疲劳问卷。使用经典的临界值(流行病学研究中心抑郁量表得分≥17,马斯特里赫特问卷得分≥8),无冠心病的受试者中分别有6.5%和9.8%被归类为抑郁和过度疲劳,而有冠心病的受试者中这一比例分别为38%和48.1%。冠心病患者年龄更大,体重指数更高,总胆固醇、血糖、纤溶酶原激活物抑制剂1(PAI - 1)、组织纤溶酶原激活物(t - PA)抗原和纤维蛋白原水平更高;47%的患者接受过高血压治疗。抑郁受试者的PAI - 1活性水平更高(p = 0.006),过度疲劳患者的PAI - 1活性水平更高(p = 0.011)以及纤维蛋白原水平更高(p = 0.009)。在对临床状况(有无冠心病)、吸烟、高血压、甘油三酯浓度和体重指数进行调整后,抑郁受试者的PAI - 1活性仍然更高(p = 0.03)。在进一步对过度疲劳或t - PA抗原及纤维蛋白原水平进行调整后,这种关联依然存在。在多变量分析中,t - PA抗原和纤维蛋白原水平与抑郁情绪无关。在多变量分析中,没有纤维蛋白溶解变量与过度疲劳有关。总之,抑郁情绪而非过度疲劳与较高水平的PAI - 1活性相关,提示可能存在纤维蛋白溶解功能受损,并表明抑郁情绪可能作为心血管危险因素的一种潜在附加机制。

相似文献

1
Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.冠心病患者与非冠心病患者抑郁情绪与纤溶酶原激活物抑制剂、组织纤溶酶原激活物及纤维蛋白原水平的关系。
Am J Cardiol. 2006 May 1;97(9):1287-91. doi: 10.1016/j.amjcard.2005.11.062. Epub 2006 Mar 20.
2
Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.生长激素缺乏的成年人长期接受生长激素治疗可降低纤溶酶原激活物抑制剂-1和组织纤溶酶原激活物水平。
Thromb Haemost. 1996 Sep;76(3):422-8.
3
Fibrinolytic activity in peripheral atherosclerosis in the elderly.老年人外周动脉粥样硬化中的纤溶活性。
Thromb Haemost. 1999 Feb;81(2):275-80.
4
Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.南印度男性受试者中组织型纤溶酶原激活剂、纤溶酶原激活剂抑制剂-1和纤维蛋白原与冠状动脉疾病的关系。
J Assoc Physicians India. 2002 Jul;50:901-6.
5
Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.杂合子家族性高胆固醇血症心肌梗死年轻幸存者的纤溶参数与胰岛素抵抗
Wien Klin Wochenschr. 2001 Feb 15;113(3-4):113-8.
6
Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.在一项心肌梗死前瞻性研究(PRIME研究,即心肌梗死前瞻性流行病学研究)的10500名男性参与者中,纤维蛋白原、凝血因子VII和纤溶酶原激活物抑制剂-1与基线检查结果的相关性。
Thromb Haemost. 1998 Nov;80(5):749-56.
7
Sex differences in the determinants of fibrinolytic activity.纤溶活性决定因素中的性别差异。
Thromb Haemost. 1998 Mar;79(3):587-90.
8
[Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus].[1型和2型糖尿病患者血液中组织型纤溶酶原激活物(T-PA)、其抑制剂(PAI-1)和纤维蛋白原的水平]
Cas Lek Cesk. 1996 Mar 20;135(6):174-7.
9
[Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].[冠状动脉疾病患者纤溶酶原激活物抑制剂活性增加导致纤溶能力下降]
Helv Chir Acta. 1992 Jan;58(4):503-8.
10
Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.既往有妊娠期糖尿病的胰岛素抵抗女性的纤溶功能障碍。
Eur J Clin Invest. 2006 May;36(5):345-52. doi: 10.1111/j.1365-2362.2006.01630.x.

引用本文的文献

1
Relationship between cellular aging, perceived stress, and cardiometabolic disease risk in Black family caregivers of persons with dementia.痴呆症患者黑人家庭照顾者的细胞衰老、感知压力与心脏代谢疾病风险之间的关系。
Alzheimers Dement. 2025 Jul;21(7):e70518. doi: 10.1002/alz.70518.
2
Accelerated epigenetic aging and decreased natural killer cells based on DNA methylation in patients with untreated major depressive disorder.基于DNA甲基化的未治疗的重度抑郁症患者表观遗传加速衰老及自然杀伤细胞减少
NPJ Aging. 2023 Sep 6;9(1):19. doi: 10.1038/s41514-023-00117-1.
3
Glucocorticoid-Responsive Tissue Plasminogen Activator (tPA) and Its Inhibitor Plasminogen Activator Inhibitor-1 (PAI-1): Relevance in Stress-Related Psychiatric Disorders.
糖皮质激素反应性组织纤溶酶原激活物(tPA)及其抑制剂纤溶酶原激活物抑制剂-1(PAI-1):与应激相关精神障碍的相关性。
Int J Mol Sci. 2023 Feb 24;24(5):4496. doi: 10.3390/ijms24054496.
4
Plasminogen Activator Inhibitor-1: Potential Inflammatory Marker in Late-life Depression.纤溶酶原激活物抑制剂-1:老年抑郁症潜在的炎症标志物。
Clin Psychopharmacol Neurosci. 2023 Feb 28;21(1):147-161. doi: 10.9758/cpn.2023.21.1.147.
5
Evaluation of Circulating Platelet Extracellular Vesicles and Hypertension Mediated Organ Damage.循环血小板细胞外囊泡与高血压介导的器官损伤评估。
Int J Mol Sci. 2022 Dec 2;23(23):15150. doi: 10.3390/ijms232315150.
6
Serum plasminogen activator inhibitor-1 levels in patients with major depressive disorder vs. healthy controls: a systematic review and meta-analysis.**血清纤溶酶原激活物抑制剂-1 在重性抑郁症患者与健康对照者中的水平比较:一项系统评价和荟萃分析**。
Trends Psychiatry Psychother. 2023;45:e20230338. doi: 10.47626/2237-6089-2021-0338. Epub 2021 Nov 19.
7
Anticoagulants and the Hemostatic System: A Primer for Occupational Stress Researchers.抗凝剂与止血系统:职业应激研究人员入门。
Int J Environ Res Public Health. 2021 Oct 11;18(20):10626. doi: 10.3390/ijerph182010626.
8
Mechanisms affecting brain remodeling in depression: do all roads lead to impaired fibrinolysis?影响抑郁症大脑重塑的机制:所有途径都会导致纤维蛋白溶解受损吗?
Mol Psychiatry. 2022 Jan;27(1):525-533. doi: 10.1038/s41380-021-01264-1. Epub 2021 Aug 17.
9
Inflammation-driven brain and gut barrier dysfunction in stress and mood disorders.应激和心境障碍相关的炎症驱动的脑-肠屏障功能障碍。
Eur J Neurosci. 2022 May;55(9-10):2851-2894. doi: 10.1111/ejn.15239. Epub 2021 May 17.
10
PAI-1 protein is a key molecular effector in the transition from normal to PTSD-like fear memory.PAI-1 蛋白是从正常到 PTSD 样恐惧记忆转变中的关键分子效应物。
Mol Psychiatry. 2021 Sep;26(9):4968-4981. doi: 10.1038/s41380-021-01024-1. Epub 2021 Jan 28.